PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
140.15
Positive P/E while Healthcare median is negative at -3.48. Peter Lynch would investigate competitive advantages in a distressed Healthcare.
73.08
P/S exceeding 1.5x Healthcare median of 12.21. Jim Chanos would check for potential multiple compression risks.
5.34
P/B exceeding 1.5x Healthcare median of 2.90. Jim Chanos would check for potential asset write-down risks.
-131.29
Negative FCF while Healthcare median P/FCF is -14.15. Seth Klarman would investigate cash flow improvement potential.
-298.73
Negative operating cash flow while Healthcare median P/OCF is -11.33. Seth Klarman would investigate operational improvement potential.
5.34
Fair value ratio exceeding 1.5x Healthcare median of 2.95. Jim Chanos would check for valuation bubble risks.
0.18%
Positive earnings while Healthcare median shows losses. Peter Lynch would examine earnings quality advantage.
-0.76%
Negative FCF while Healthcare median yield is -0.65%. Seth Klarman would investigate cash flow improvement potential.